Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts

Vaccines

Free Subscription Articles published in MMWR Morb Mortal Wkly Rep Retrieve available abstracts of 57 articles: HTML format

Single Articles

March 2025
1. HUSEYNOV S, Saxentoff E, Diedrich S, Martin J, et al
   Notes from the Field: Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater - Five European Countries, September-December 2024.
   MMWR Morb Mortal Wkly Rep. 2025;74:122-124.
   PubMed    
   
   
   February 2025
2. FRUTOS AM, Cleary S, Reeves EL, Ahmad HM, et al
   Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025.
   MMWR Morb Mortal Wkly Rep. 2025;74:83-90.
   PubMed     Abstract available
   
   
   
3. GARGANO JW, Stefanos R, Dahl RM, Castilho JL, et al
   Trends in Cervical Precancers Identified Through Population-Based Surveillance - Human Papillomavirus Vaccine Impact Monitoring Project, Five Sites, United States, 2008-2022.
   MMWR Morb Mortal Wkly Rep. 2025;74:96-101.
   PubMed     Abstract available
   
   
   
4. LINK-GELLES R, Chickery S, Webber A, Ong TC, et al
   Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged >/=18 Years - VISION and IVY Networks, September 2024-January 2025.
   MMWR Morb Mortal Wkly Rep. 2025;74:73-82.
   PubMed     Abstract available
   
   
   January 2025
5. KOBAYASHI M, Leidner AJ, Gierke R, Xing W, et al
   Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged >/=50 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
   MMWR Morb Mortal Wkly Rep. 2025;74:1-8.
   PubMed     Abstract available
   
   
   December 2024
6. SCHILLIE S, Loehr J, Chen WH, Moser CA, et al
   New Dosing Interval and Schedule for the Bexsero MenB-4C Vaccine: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, October 2024.
   MMWR Morb Mortal Wkly Rep. 2024;73:1124-1128.
   PubMed     Abstract available
   
   
   
7. HARDY CM, Rathee M, Chaudhury S, Wadood MZ, et al
   Progress Toward Poliomyelitis Eradication - Afghanistan, January 2023-September 2024.
   MMWR Morb Mortal Wkly Rep. 2024;73:1129-1134.
   PubMed     Abstract available
   
   
   
8. SANDUL AL, Rapposelli K, Nyendak M, Kim M, et al
   Updated Recommendation for Universal Hepatitis B Vaccination in Adults Aged 19-59 Years - United States, 2024.
   MMWR Morb Mortal Wkly Rep. 2024;73:1106.
   PubMed     Abstract available
   
   
   November 2024
9. RESES HE, Segovia G, Dubendris H, Barbre K, et al
   Coverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents - National Healthcare Safety Network, United States, November 2024.
   MMWR Morb Mortal Wkly Rep. 2024;73:1052-1057.
   PubMed     Abstract available
   
   
   
10. KRISS JL, Black CL, Razzaghi H, Meghani M, et al
    Influenza, COVID-19, and Respiratory Syncytial Virus Vaccination Coverage Among Adults - United States, Fall 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:1044-1051.
    PubMed     Abstract available
    
    
    
11. STEFANOS R, Schatzman S, Wakeman B, Raines K, et al
    Pediatric Rash Illness Outbreak with Initial Positive Measles Immunoglobulin M Antibody Test Results - American Samoa, March-July 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:1030-1035.
    PubMed     Abstract available
    
    
    
12. MINTA AA, Ferrari M, Antoni S, Lambert B, et al
    Progress Toward Measles Elimination - Worldwide, 2000-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:1036-1042.
    PubMed     Abstract available
    
    
    October 2024
13. SUN J, Zhang Y, Zhou S, Song Y, et al
    Laboratory-Confirmed Influenza Hospitalizations During Pregnancy or the Early Postpartum Period - Suzhou City, Jiangsu Province, China, 2018-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:958-964.
    PubMed     Abstract available
    
    
    
14. JONES CE, Danovaro-Holliday MC, Mwinnyaa G, Gacic-Dobo M, et al
    Routine Vaccination Coverage - Worldwide, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:978-984.
    PubMed     Abstract available
    
    
    
15. BELL J, Meng L, Barbre K, Wong E, et al
    Influenza and COVID-19 Vaccination Coverage Among Health Care Personnel - National Healthcare Safety Network, United States, 2023-24 Respiratory Virus Season.
    MMWR Morb Mortal Wkly Rep. 2024;73:966-972.
    PubMed     Abstract available
    
    
    
16. STEIN SR, Beron AJ, Nelson KM, Price E, et al
    Notes from the Field: Enhanced Surveillance for Raccoon Rabies Virus Variant and Vaccination of Wildlife for Management - Omaha, Nebraska, October 2023-July 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:933-935.
    PubMed     Abstract available
    
    
    
17. NAMAGEYO-FUNA A, Greene SA, Henderson E, Traore MA, et al
    Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2023-June 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:909-916.
    PubMed     Abstract available
    
    
    
18. SEITHER R, Yusuf OB, Dramann D, Calhoun K, et al
    Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten - United States, 2023-24 School Year.
    MMWR Morb Mortal Wkly Rep. 2024;73:925-932.
    PubMed     Abstract available
    
    
    
19. ZENO EE, Nogareda F, Regan A, Couto P, et al
    Interim Effectiveness Estimates of 2024 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalization - REVELAC-i Network, Five South American Countries, March-July 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:861-868.
    PubMed     Abstract available
    
    
    September 2024
20. HAVERS FP, Whitaker M, Chatwani B, Patton ME, et al
    COVID-19-Associated Hospitalizations and Maternal Vaccination Among Infants Aged <6 Months - COVID-NET, 12 States, October 2022-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:830-836.
    PubMed     Abstract available
    
    
    
21. HILL HA, Yankey D, Elam-Evans LD, Mu Y, et al
    Decline in Vaccination Coverage by Age 24 Months and Vaccination Inequities Among Children Born in 2020 and 2021 - National Immunization Survey-Child, United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:844-853.
    PubMed     Abstract available
    
    
    
22. RAZZAGHI H, Garacci E, Kahn KE, Lindley MC, et al
    Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:837-843.
    PubMed     Abstract available
    
    
    
23. TIPPINS A, Boyd EM, Coy KC, Mutamba G, et al
    Vaccination Coverage by Age 24 Months Among Children Born During 2017-2021 - U.S.-Affiliated Pacific Islands.
    MMWR Morb Mortal Wkly Rep. 2024;73:854-859.
    PubMed     Abstract available
    
    
    
24. PANAGIOTAKOPOULOS L, Moulia DL, Godfrey M, Link-Gelles R, et al
    Use of COVID-19 Vaccines for Persons Aged >/=6 Months: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024-2025.
    MMWR Morb Mortal Wkly Rep. 2024;73:819-824.
    PubMed     Abstract available
    
    
    
25. COLLINS JP, Loehr J, Chen WH, Clark M, et al
    Use of Haemophilus influenzae Type b-Containing Vaccines Among American Indian and Alaska Native Infants: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:799-802.
    PubMed     Abstract available
    
    
    
26. MBAEYI C, Ul Haq A, Safdar RM, Khan Z, et al
    Progress Toward Poliomyelitis Eradication - Pakistan, January 2023-June 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:788-792.
    PubMed     Abstract available
    
    
    
27. KOBAYASHI M, Leidner AJ, Gierke R, Farrar JL, et al
    Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:793-798.
    PubMed     Abstract available
    
    
    August 2024
28. VALIER MR, Yankey D, Elam-Evans LD, Chen M, et al
    Vital Signs: Trends and Disparities in Childhood Vaccination Coverage by Vaccines for Children Program Eligibility - National Immunization Survey-Child, United States, 2012-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:722-730.
    PubMed     Abstract available
    
    
    
29. PINGALI C, Yankey D, Chen M, Elam-Evans LD, et al
    National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:708-714.
    PubMed     Abstract available
    
    
    
30. TIPPINS A, Mutamba G, Boyd EM, Coy KC, et al
    Human Papillomavirus Vaccination Coverage Among Adolescent Girls Aged 13-17 Years - U.S.-Affiliated Pacific Islands, 2013-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:715-721.
    PubMed     Abstract available
    
    
    
31. FREEDMAN MS, Swisher SD, Wallace RM, Laughlin ME, et al
    Notes from the Field: Heightened Precautions for Imported Dogs Vaccinated with Potentially Ineffective Rabies Vaccine - United States, August 2021-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:706-707.
    PubMed    
    
    
    
32. BRITTON A, Roper LE, Kotton CN, Hutton DW, et al
    Use of Respiratory Syncytial Virus Vaccines in Adults Aged >/=60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:696-702.
    PubMed     Abstract available
    
    
    
33. ZHOU F, Jatlaoui TC, Leidner AJ, Carter RJ, et al
    Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:682-685.
    PubMed     Abstract available
    
    
    
34. TOHME RA, Shadaker S, Adamia E, Khonelidze I, et al
    Progress Toward the Elimination of Hepatitis B and Hepatitis C in the Country of Georgia, April 2015-April 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:660-666.
    PubMed     Abstract available
    
    
    July 2024
35. ALLEMAN MM, Sereno LS, Whittembury A, Li X, et al
    Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus - Region of the Americas, 2012-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:648-655.
    PubMed     Abstract available
    
    
    June 2024
36. MENDES A, Mohamed GA, Derow M, Stehling-Ariza T, et al
    Persistent Transmission of Circulating Vaccine-Derived Poliovirus - Somalia, January 2017-March 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:575-580.
    PubMed     Abstract available
    
    
    
37. ADEGOKE OJ, Rachlin A, Porter AM, Katsande R, et al
    Migration from Epi Info to District Health Information Software 2 for Vaccine-Preventable Disease Surveillance - World Health Organization African Region, 2019-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:529-533.
    PubMed     Abstract available
    
    
    May 2024
38. HAUSE AM, Moro PL, Baggs J, Zhang B, et al
    Early Safety Findings Among Persons Aged >/=60 Years Who Received a Respiratory Syncytial Virus Vaccine - United States, May 3, 2023-April 14, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:489-494.
    PubMed    
    
    
    
39. GUAGLIARDO SAJ, Kracalik I, Carter RJ, Braden C, et al
    Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine - United States, May 2022-May 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:460-466.
    PubMed     Abstract available
    
    
    
40. GEIGER K, Stehling-Ariza T, Bigouette JP, Bennett SD, et al
    Progress Toward Poliomyelitis Eradication - Worldwide, January 2022-December 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:441-446.
    PubMed     Abstract available
    
    
    
41. GRESSICK K, Nham A, Filardo TD, Anderson K, et al
    Measles Outbreak Associated with a Migrant Shelter - Chicago, Illinois, February-May 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:424-429.
    PubMed     Abstract available
    
    
    April 2024
42. PANAGIOTAKOPOULOS L, Godfrey M, Moulia DL, Link-Gelles R, et al
    Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged >/=65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:377-381.
    PubMed     Abstract available
    
    
    
43. KALLAY R, Doshi RH, Muhoza P, Choi MJ, et al
    Use of Ebola Vaccines - Worldwide, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:360-364.
    PubMed     Abstract available
    
    
    
44. COLLINS JP, Crowe SJ, Ortega-Sanchez IR, Bahta L, et al
    Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged >/=10 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:345-350.
    PubMed     Abstract available
    
    
    
45. ZAMBRANO LD, Newhams MM, Simeone RM, Payne AB, et al
    Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:330-338.
    PubMed     Abstract available
    
    
    
46. FRANKLIN D, Barbre K, Rowe TA, Reses HE, et al
    COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:339-344.
    PubMed     Abstract available
    
    
    
47. LIKO J, Cieslak PR
    Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:317-320.
    PubMed     Abstract available
    
    
    
48. DOSHI RH, Nsasiirwe S, Dahlke M, Atagbaza A, et al
    COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:307-311.
    PubMed     Abstract available
    
    
    
49. MATHIS AD, Raines K, Masters NB, Filardo TD, et al
    Measles - United States, January 1, 2020-March 28, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:295-300.
    PubMed     Abstract available
    
    
    
50. EL KALACH R, Jones-Jack N, Elam MA, Olorukooba A, et al
    Federal Retail Pharmacy Program Contributions to Bivalent mRNA COVID-19 Vaccinations Across Sociodemographic Characteristics - United States, September 1, 2022-September 30, 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:286-290.
    PubMed     Abstract available
    
    
    March 2024
51. LINK-GELLES R, Rowley EAK, DeSilva MB, Dascomb K, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Hospitalization Among Adults Aged >/=18 Years with Immunocompromising Conditions - VISION Network, September 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:271-276.
    PubMed     Abstract available
    
    
    
52. THOMAS CM, Hartley A, Schmitz A, Reid HD, et al
    Implications of Measles Inclusion by Commercial Syndromic Polymerase Chain Reaction Panels - United States, May 2022-April 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:260-264.
    PubMed     Abstract available
    
    
    
53. MOLINE HL, Tannis A, Toepfer AP, Williams JV, et al
    Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:209-214.
    PubMed     Abstract available
    
    
    February 2024
54. ZHU S, Quint J, Leon TM, Sun M, et al
    Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza - California, October 2023-January 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:175-179.
    PubMed     Abstract available
    
    
    
55. DECUIR J, Payne AB, Self WH, Rowley EAK, et al
    Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged >/=18 Years - VISION and IVY Networks,
    MMWR Morb Mortal Wkly Rep. 2024;73:180-188.
    PubMed     Abstract available
    
    
    
56. FRUTOS AM, Price AM, Harker E, Reeves EL, et al
    Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness - United States.
    MMWR Morb Mortal Wkly Rep. 2024;73:168-174.
    PubMed     Abstract available
    
    
    
57. OU AC, Zimmerman LA, Alexander JP Jr, Crowcroft NS, et al
    Progress Toward Rubella and Congenital Rubella Syndrome Elimination - Worldwide, 2012-2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:162-167.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.